COMMENT
Sandoz spin-off continues Novartis’s focus on innovation
High risk, high reward – the future of CAR-T therapy in CLL
bluebird bio bags successive landmark FDA approvals for gene therapies
Urgent need to update Canada’s breast cancer screening guidelines
The epidemiology of RSV changed in UK children during the pandemic
Sandoz spin-off continues Novartis’ focus on innovation
High risk, high reward – the future of CAR-T therapy in CLL
bluebird bio bags successive landmark FDA approvals for gene therapies
Urgent need to update Canada’s breast cancer screening guidelines
The epidemiology of RSV changed in UK children during the pandemic